Alzamend Neuro's market cap is currently $8.04M. The company's EPS TTM is $-3.064; its P/E ratio is ―; Alzamend Neuro is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
